Abstract
ObjectivesWe conducted a randomised, double blind, placebo controlled trial to assess the efficacy and safety of cilostazol, a selective inhibitor of phosphodiesterase 3, in patients with vasospastic angina (VSA).BackgroundCilostazol has...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have